Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2026-05-07 @ 8:29 PM
Study NCT ID:
NCT04523220
Status:
COMPLETED
Last Update Posted:
2023-07-21
First Post:
2020-08-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis
Sponsor:
Bayer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
20115
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None